243 related articles for article (PubMed ID: 32303175)
41. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.
Fishman-Jacob T; Youdim MBH
J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186
[TBL] [Abstract][Full Text] [Related]
42. Complementation of dopaminergic signaling by Pitx3-GDNF synergy induces dopamine secretion by multipotent Ntera2 cells.
Eskandarian Boroujeni M; Aliaghaei A; Maghsoudi N; Gardaneh M
J Cell Biochem; 2020 Jan; 121(1):200-212. PubMed ID: 31310388
[TBL] [Abstract][Full Text] [Related]
43. TREM2 gene induces differentiation of induced pluripotent stem cells into dopaminergic neurons and promotes neuronal repair via TGF-β activation in 6-OHDA-lesioned mouse model of Parkinson's disease.
Liang H; Liu P; Wang Z; Xiong H; Yin C; Zhao D; Wu C; Chen L
CNS Neurosci Ther; 2024 Feb; 30(2):e14630. PubMed ID: 38348765
[TBL] [Abstract][Full Text] [Related]
44. Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model.
Tentillier N; Etzerodt A; Olesen MN; Rizalar FS; Jacobsen J; Bender D; Moestrup SK; Romero-Ramos M
J Neurosci; 2016 Sep; 36(36):9375-90. PubMed ID: 27605613
[TBL] [Abstract][Full Text] [Related]
45. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
46. Dopaminergic differentiation of stem cells from human deciduous teeth and their therapeutic benefits for Parkinsonian rats.
Fujii H; Matsubara K; Sakai K; Ito M; Ohno K; Ueda M; Yamamoto A
Brain Res; 2015 Jul; 1613():59-72. PubMed ID: 25863132
[TBL] [Abstract][Full Text] [Related]
47. Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease.
Sharma R; McMillan CR; Niles LP
J Pineal Res; 2007 Oct; 43(3):245-54. PubMed ID: 17803521
[TBL] [Abstract][Full Text] [Related]
48. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
49. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.
Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J
Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006
[TBL] [Abstract][Full Text] [Related]
50. The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.
Ratzka A; Kalve I; Özer M; Nobre A; Wesemann M; Jungnickel J; Köster-Patzlaff C; Baron O; Grothe C
Cell Transplant; 2012; 21(4):749-62. PubMed ID: 21929871
[TBL] [Abstract][Full Text] [Related]
51. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
[TBL] [Abstract][Full Text] [Related]
52. Chronic and progressive dopaminergic neuronal death in substantia nigra associates with a decrease in serum levels of glucose and free fatty acids, the role of interlokin-1 beta.
Sarbazi-Golezari A; Haghdoost-Yazdi H
Metab Brain Dis; 2022 Feb; 37(2):373-381. PubMed ID: 34767157
[TBL] [Abstract][Full Text] [Related]
53. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
54. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
[TBL] [Abstract][Full Text] [Related]
55. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
Yong Y; Ding H; Fan Z; Luo J; Ke ZJ
Neurochem Res; 2011 Mar; 36(3):367-74. PubMed ID: 21203835
[TBL] [Abstract][Full Text] [Related]
56. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
57. Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.
Singh S; Mishra A; Srivastava N; Shukla R; Shukla S
Mol Neurobiol; 2018 Jan; 55(1):583-602. PubMed ID: 27975173
[TBL] [Abstract][Full Text] [Related]
58. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.
Bagheri-Mohammadi S; Alani B; Karimian M; Moradian-Tehrani R; Noureddini M
Mol Biol Rep; 2019 Aug; 46(4):4293-4302. PubMed ID: 31123907
[TBL] [Abstract][Full Text] [Related]
59. Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.
Yang M; Donaldson AE; Marshall CE; Shen J; Iacovitti L
Cell Transplant; 2004; 13(5):535-47. PubMed ID: 15565866
[TBL] [Abstract][Full Text] [Related]
60. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease.
Marin C; Bonastre M; Fuentes M; Mullol J
Pharmacol Biochem Behav; 2020 Oct; 197():173013. PubMed ID: 32758524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
